The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses
中国首个选择性VAP-1抑制剂TT-01025-CL:单次和多次递增剂量给药的安全性、耐受性、药代动力学和药效学研究
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1327008
Yang, Yuanxun; Yu, Lei; Sheng, Zejuan; Lin, Hui; Weng, Zuyi; Song, Wei; Cao, Bei; Zhao, Yu; Gao, Yingsheng; Ni, Shumao; Wang, Huimin; Ma, Tingting; Huang, Lei; Sun, Caixia; Li, Juan